Microbial Warfare on Three Fronts: Mixed Biofilm of

Aspergillus fumigatus Staphylococcus aureus fungal–bacterial interaction human limbo-corneal fibroblast cells mixed fungal–bacterial biofilms

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2021
Historique:
received: 24 12 2020
accepted: 19 07 2021
entrez: 6 9 2021
pubmed: 7 9 2021
medline: 21 10 2021
Statut: epublish

Résumé

Coinfections with fungi and bacteria in ocular pathologies are increasing at an alarming rate. Two of the main etiologic agents of infections on the corneal surface, such as To determine the capacity of biofilm formation during this fungal-bacterial interaction on primary limbo-corneal fibroblast monolayers. The biofilm on the limbo-corneal fibroblast culture was analyzed by assessing biomass production and determining metabolic activity. Furthermore, the mixed biofilm effect on this cell culture was observed with several microscopy techniques. The single and mixed biofilm was higher on the limbo-corneal fibroblast monolayer than on abiotic surfaces. The This is the first report of mixed fungal-bacterial biofilm production and morphological characterization on the limbo-corneal fibroblast monolayer. Three antibiosis behaviors were observed between fungi, bacteria, and limbo-corneal fibroblasts. The mycophagy effect over

Sections du résumé

Background
Coinfections with fungi and bacteria in ocular pathologies are increasing at an alarming rate. Two of the main etiologic agents of infections on the corneal surface, such as
Objective
To determine the capacity of biofilm formation during this fungal-bacterial interaction on primary limbo-corneal fibroblast monolayers.
Results
The biofilm on the limbo-corneal fibroblast culture was analyzed by assessing biomass production and determining metabolic activity. Furthermore, the mixed biofilm effect on this cell culture was observed with several microscopy techniques. The single and mixed biofilm was higher on the limbo-corneal fibroblast monolayer than on abiotic surfaces. The
Conclusion
This is the first report of mixed fungal-bacterial biofilm production and morphological characterization on the limbo-corneal fibroblast monolayer. Three antibiosis behaviors were observed between fungi, bacteria, and limbo-corneal fibroblasts. The mycophagy effect over

Identifiants

pubmed: 34485167
doi: 10.3389/fcimb.2021.646054
pmc: PMC8415486
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

646054

Informations de copyright

Copyright © 2021 Ramírez-Granillo, Bautista-Hernández, Bautista-De Lucío, Magaña-Guerrero, Domínguez-López, Córdova-Alcántara, Pérez, Martínez-Rivera and Rodríguez-Tovar.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Med Microbiol. 2007 Sep;56(Pt 9):1205-1212
pubmed: 17761484
BMC Microbiol. 2015 Feb 15;15:33
pubmed: 25880740
Am J Physiol. 1999 Jul;277(1):L204-17
pubmed: 10409249
J Clin Microbiol. 1985 Dec;22(6):996-1006
pubmed: 3905855
Biomed Res Int. 2017;2017:9042851
pubmed: 28691037
Clin Infect Dis. 2005 Aug 15;41(4):521-6
pubmed: 16028162
Vet Microbiol. 2018 Mar;216:218-222
pubmed: 29519520
Trends Microbiol. 2000 Aug;8(8):341-3
pubmed: 10920387
Front Microbiol. 2012 Sep 26;3:346
pubmed: 23055997
Int Ophthalmol. 2020 Oct;40(10):2771-2788
pubmed: 32500305
Crit Rev Microbiol. 2009;35(4):340-55
pubmed: 19863383
Pol J Microbiol. 2005;54(3):191-200
pubmed: 16450834
Curr Opin Microbiol. 2006 Aug;9(4):359-64
pubmed: 16777473
FEMS Microbiol Lett. 2010 Dec;313(2):96-102
pubmed: 20964704
BMC Microbiol. 2016 Oct 18;16(1):243
pubmed: 27756222
J Infect Chemother. 2012 Oct;18(5):698-703
pubmed: 22410856
J Bacteriol. 2001 Sep;183(18):5385-94
pubmed: 11514524
Rev Chilena Infectol. 2008 Aug;25(4):295-300
pubmed: 18769780
J Microbiol Methods. 2012 Aug;90(2):96-9
pubmed: 22561094
Virulence. 2011 Sep-Oct;2(5):445-59
pubmed: 21921685
Ophthalmology. 2001 Jun;108(6):1088-92
pubmed: 11382634
Nat Rev Microbiol. 2014 Jan;12(1):49-62
pubmed: 24336184
Clin Microbiol Rev. 2002 Apr;15(2):155-66
pubmed: 11932228
Acta Ophthalmol. 2020 Nov;98(7):e895-e900
pubmed: 32190979
PLoS Pathog. 2012;8(4):e1002585
pubmed: 22496639
Invest Ophthalmol Vis Sci. 2011 Jul 20;52(8):5408-13
pubmed: 21571682
Cell Microbiol. 2015 Oct;17(10):1442-6
pubmed: 26243723
J Bacteriol. 2007 Jul;189(13):4815-26
pubmed: 17483230
Cold Spring Harb Perspect Med. 2014 Nov 03;4(11):a015297
pubmed: 25368015
J Biomed Mater Res A. 2016 Jan;104(1):272-82
pubmed: 26375405
Front Microbiol. 2016 Apr 07;7:472
pubmed: 27092126
Front Cell Infect Microbiol. 2014 Jul 29;4:101
pubmed: 25120959
Invest Ophthalmol Vis Sci. 2012 Nov 21;53(12):7774-8
pubmed: 23099491
Front Microbiol. 2017 Jul 19;8:1354
pubmed: 28769913
Curr Opin Microbiol. 2009 Aug;12(4):350-7
pubmed: 19546023
J Autoimmun. 2013 Sep;45:7-14
pubmed: 23871641
Rev Iberoam Micol. 2010 Jun 30;27(2):57-61
pubmed: 20346302
Microbiology (Reading). 2009 Jan;155(Pt 1):46-52
pubmed: 19118345
Microb Pathog. 2019 Oct;135:103644
pubmed: 31351106
Fungal Genet Biol. 2007 Jun;44(6):484-91
pubmed: 17267249
Future Microbiol. 2015;10(12):1997-2015
pubmed: 26592098
Microbiol Mol Biol Rev. 2011 Dec;75(4):583-609
pubmed: 22126995
Infect Immun. 2002 Aug;70(8):4697-700
pubmed: 12117986
Pathogens. 2015 Mar 23;4(1):111-36
pubmed: 25806622
Cornea. 1996 May;15(3):301-4
pubmed: 8713934
Clin Microbiol Rev. 2012 Jan;25(1):193-213
pubmed: 22232376
Nat Commun. 2018 Sep 20;9(1):3835
pubmed: 30237437
Eur Cell Mater. 2002 Dec 31;4:39-60
pubmed: 14562246
Cell Microbiol. 2009 Jan;11(1):170-82
pubmed: 19016788
Eur J Microbiol Immunol (Bp). 2017 Aug 19;7(3):151-157
pubmed: 29034104
Yale J Biol Med. 2016 Sep 30;89(3):325-330
pubmed: 27698616
J Antimicrob Chemother. 2000 Sep;46(3):397-403
pubmed: 10980166
Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5116-5126
pubmed: 27699405
Biotechnol Bioeng. 1982 Feb;24(2):501-6
pubmed: 18546318
Microb Pathog. 2020 Mar;140:103953
pubmed: 31904447
Gac Med Mex. 2007 May-Jun;143(3):183-7
pubmed: 17722444
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1511-6
pubmed: 19875664
Int J Mol Sci. 2020 Jul 29;21(15):
pubmed: 32751072
Ocul Surf. 2016 Jul;14(3):342-9
pubmed: 27189865
Biofilm. 2019 Nov 19;2:100010
pubmed: 33447797
Prog Mol Biol Transl Sci. 2013;116:95-118
pubmed: 23481192
Pathogens. 2013 Feb 04;2(1):13-32
pubmed: 25436879
Front Microbiol. 2018 Aug 30;9:2031
pubmed: 30214437
Clin Microbiol Rev. 2009 Jul;22(3):447-65
pubmed: 19597008
Infect Immun. 1996 Jun;64(6):2288-94
pubmed: 8675339
New Phytol. 2008;177(4):859-876
pubmed: 18086226
Cornea. 2015 Jul;34(7):778-85
pubmed: 25811724
J Biol Chem. 2017 Apr 28;292(17):7258-7273
pubmed: 28289096
Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11633-8
pubmed: 17620618
Virulence. 2010 Jul-Aug;1(4):223-35
pubmed: 21178448
Ophthalmic Plast Reconstr Surg. 2013 Sep-Oct;29(5):376-81
pubmed: 23880975
J Microbiol. 2019 Jun;57(6):485-497
pubmed: 31134579
Eukaryot Cell. 2012 Jan;11(1):68-78
pubmed: 21724936
Microbiol Spectr. 2017 Apr;5(2):
pubmed: 28429675
Ophthalmic Plast Reconstr Surg. 2010 Nov-Dec;26(6):426-30
pubmed: 20683273
Acta Biochim Pol. 2009;56(2):211-24
pubmed: 19543556
Retina. 1999;19(5):447-50
pubmed: 10546943
Curr Opin Immunol. 2011 Aug;23(4):473-80
pubmed: 21856139

Auteurs

Adrián Ramírez-Granillo (A)

Medical Mycology Laboratory, National School of Biological Sciences (ENCB)-Instituto Politécnico Nacional (IPN), Department of Microbiology, Mexico City, Mexico.

Luis Antonio Bautista-Hernández (LA)

Ocular Microbiology and Proteomics Laboratory, Research Unit, "Conde de Valenciana Private Assistance Foundation", Mexico City, Mexico.

Víctor Manuel Bautista-De Lucío (VM)

Ocular Microbiology and Proteomics Laboratory, Research Unit, "Conde de Valenciana Private Assistance Foundation", Mexico City, Mexico.

Fátima Sofía Magaña-Guerrero (FS)

Cell Biology and Amniotic Membrane Laboratory, Research Unit, "Conde de Valenciana Private Assistance Foundation", Mexico City, Mexico.

Alfredo Domínguez-López (A)

Cell Biology and Amniotic Membrane Laboratory, Research Unit, "Conde de Valenciana Private Assistance Foundation", Mexico City, Mexico.

Itzel Margarita Córdova-Alcántara (IM)

Medical Mycology Laboratory, National School of Biological Sciences (ENCB)-Instituto Politécnico Nacional (IPN), Department of Microbiology, Mexico City, Mexico.

Néstor O Pérez (NO)

Research and Development Department Probiomed SA de CV, Tenancingo Edo de Mex, Mexico.

María de Los Angeles Martínez-Rivera (MLA)

Medical Mycology Laboratory, National School of Biological Sciences (ENCB)-Instituto Politécnico Nacional (IPN), Department of Microbiology, Mexico City, Mexico.

Aída Verónica Rodríguez-Tovar (AV)

Medical Mycology Laboratory, National School of Biological Sciences (ENCB)-Instituto Politécnico Nacional (IPN), Department of Microbiology, Mexico City, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH